Phase
Condition
Retina
Macular Degeneration
Treatment
ZEISS disposable
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Voluntary written informed consent of the participant or their legally authorizedrepresentative has been obtained prior to any screening procedures
Patients that are scheduled for primary vitrectomy surgery to treat retinaldetachment or macular disease (pucker, macular hole, vitreomacular traction).
Both vitrectomy-only and combined phaco-vitrectomy surgeries
General or local anesthesia, or combination
Exclusion
Exclusion Criteria:
Patient who do not have sufficient command of the Dutch language to read andunderstand the informed consent form
Any disorder, which in the investigator's opinion might jeopardise participant'ssafety or compliance with the CIP.
Repeat vitrectomy surgery
Study Design
Study Description
Connect with a study center
Universitaire Ziekenhuizen Leuven
Leuven, Vlaams-Brabant 3000
BelgiumSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.